Feature Channels:

AIDS and HIV

Add to Favorites Subscribe Share
fbshare-AIDS and HIV

Showing results

2130 of 1329

Article ID: 716216

Mount Sinai Researchers Develop Novel Vaccine That Induces Antibodies that Contribute to Protection from HIV Infection

Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have developed a novel vaccine consisting of DNA and recombinant proteins⸺proteins composed of a portion of an HIV protein and another unrelated protein.

Released:
23-Jul-2019 11:00 AM EDT
IDSA HIVMA Joint Logo.png

Article ID: 716040

Declaration of PHEIC in DRC Should Spur Support, Not Fear

Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA)

The World Health Organization’s declaration today that the year-long Ebola crisis is a Public Health Emergency of International Concern is hoped to raise much-needed awareness and resources for preparedness and control efforts across the region. The decision was made following new incidents highlighting risks of repeated cross-border spread of the ongoing Ebola outbreak in the Democratic Republic of Congo.

Released:
18-Jul-2019 1:05 PM EDT

Law and Public Policy

  • Embargo expired:
    15-Jul-2019 4:00 PM EDT

Article ID: 715613

Despite Long-Term Treatment, HIV Persists in Spinal Fluid and is Linked to Cognition Problems

Health Sciences at the University of Pittsburgh

Even after nearly a decade of strict HIV treatment, cells sheltering the virus could be found in the cerebrospinal fluid of half of participants in a national clinical trial of people living with HIV. Moreover, those participants had higher likelihood of cognitive deficits.

Released:
11-Jul-2019 11:00 AM EDT
Newswise: HIV: holes in the immune system left unrepaired despite drug therapy
  • Embargo expired:
    15-Jul-2019 11:00 AM EDT

Article ID: 715664

HIV: holes in the immune system left unrepaired despite drug therapy

Universite de Montreal

A discovery about HIV published in Nature Immunology paves the way to new therapies that might complement antiretroviral therapy.

Released:
11-Jul-2019 3:05 PM EDT
Newswise: Adults With HIV Who Have Compassionate Care Providers Start and Remain in Treatment Longer

Article ID: 715686

Adults With HIV Who Have Compassionate Care Providers Start and Remain in Treatment Longer

Rutgers University-New Brunswick

Rutgers researchers find patients who perceive their primary care providers as lacking empathy and not willing to include them in decision making are at risk for abandoning treatment or not seeking treatment at all

Released:
14-Jul-2019 10:05 AM EDT

Research Results

Channels:

AIDS and HIV, All Journal News, Infectious Diseases, Public Health

Languages:

English

Article ID: 715763

Sample-to-result DNA/RNA testing by LabTurbo SP-qPCR AIO System at Booth 864

71st AACC Annual Scientific Meeting Press Program

Taigen Bioscience Corporation welcomes you to booth 864 to see the sample-to-resultDNA/RNA testing automation by LabTurbo SP-qPCR AIO System

Released:
12-Jul-2019 3:35 PM EDT
ScreenShot2016-04-04at9.03.13PM.png
  • Embargo expired:
    10-Jul-2019 10:00 AM EDT

Article ID: 715424

Study participation cuts alcohol use and boosts viral suppression in female drinkers with HIV

Research Society on Alcoholism

Women living with HIV are less likely than men to achieve viral suppression with antiretroviral therapy. Reduction in alcohol use is a possible strategy to improve health outcomes in women with HIV, with evidence that unhealthy alcohol use (>7 drinks per week or >4 drinks per occasion for women) is associated with poorer adherence to treatment, lower rates of viral suppression, and faster disease progression. Several medications are available on prescription to help reduce drinking, including naltrexone, which is taken as a once-daily pill; however, none have been studied in relation to clinical outcomes in people with HIV. Researchers from universities in Florida have conducted a clinical trial, published in the journal Alcoholism: Clinical & Experimental Research , to understand the effect of naltrexone on drinking behavior and clinical outcomes in women with HIV who engage in unhealthy alcohol use, exceeding recommended drinking levels.

Released:
8-Jul-2019 2:05 PM EDT

Social and Behavioral Sciences

JHSPH-new-logo.jpg

Article ID: 715394

Bloomberg School Faculty Member, AIDS Researcher and Human Rights Advocate Chris Beyrer Among Finalists To Head UNAIDS

Johns Hopkins Bloomberg School of Public Health

Chris Beyrer, MD, MPH, a longtime faculty member at the Johns Hopkins Bloomberg School of Public Health, globally recognized AIDS researcher and advocate, and former president of the International AIDS Society (IAS), is among five finalists to lead the Joint United Nations Programme on HIV/AIDS.

Released:
8-Jul-2019 11:05 AM EDT
Newswise: For first time ever, researchers able to eliminate HIV from animal
  • Embargo expired:
    2-Jul-2019 11:00 AM EDT

Article ID: 715084

For first time ever, researchers able to eliminate HIV from animal

University of Nebraska Medical Center (UNMC)

For the first time researchers have been able to completely eliminate HIV from a mouse model. It marks a critical step toward the development of a possible cure for human HIV infection.

Released:
27-Jun-2019 2:05 PM EDT
NEWFredHutch_tm_v_tag_4c_rbg_Clearspace.jpg

Article ID: 715222

Tip Sheet: HIV Exclusions in Clinical Trials; Lack of Diversity in Genetic Research; And Advances in Bladder Cancer

Fred Hutchinson Cancer Research Center

Below are summaries of recent Fred Hutch research, with links for additional background and media contacts.

Released:
1-Jul-2019 4:30 PM EDT

Showing results

2130 of 1329

Chat now!